The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Focus on the Role of NLRP3 Inflammasome in Diseases
Open accessAbstract
Inflammation is a protective reaction activated in response to detrimental stimuli, such as dead cells, irritants or pathogens, by the evolutionarily conserved immune system and is regulated by the host. The inflammasomes are recognized as innate immune system sensors and receptors that manage the activation of caspase-1 and stimulate inflammation response. They have been associated with several inflammatory disorders. The NLRP3 inflammasome is the most well characterized. It is so called because NLRP3 belongs to the family of nucleotide-binding and oligomerization domain-like receptors (NLRs). Recent evidence has greatly improved our understanding of the mechanisms by which the NLRP3 inflammasome is activated. Additionally, increasing data in animal models, supported by human studies, strongly implicate the involvement of the inflammasome in the initiation or progression of disorders with a high impact on public health, such as metabolic pathologies (obesity, type 2 diabetes, atherosclerosis), cardiovascular diseases (ischemic and non-ischemic heart disease), inflammatory issues (liver diseases, inflammatory bowel diseases, gut microbiome, rheumatoid arthritis) and neurologic disorders (Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, amyotrophic lateral sclerosis and other neurological disorders), compared to other molecular platforms. This review will provide a focus on the available knowledge about the NLRP3 inflammasome role in these pathologies and describe the balance between the activation of the harmful and beneficial inflammasome so that new therapies can be created for patients with these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 1×
“One of the possible reasons of these discrepancies may be the differences in intestinal microbiota in animals bred in different facilities, because the significant role of the intestinal microbiota in metabolic diseases has been demonstrated [44].”
BackgroundCompston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 3×
“Studies in macrophages and animal models have shown that oxidized low-density lipoprotein and cholesterol crystals trigger NLRP3 inflammasome activation [8,9].”
BackgroundType 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Inflammasomes: mechanism of assembly, regulation and signalling
Broz, P., & Dixit, V. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.58 · Cited by 3,500
Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655 · cited 3×
“They also show decreased inflammatory cytokine expression in metabolic tissues (adipose tissue and liver), serum and up-regulated insulin-PI3K-Akt signaling [42,49,56,57].”
BackgroundMechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,503
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
Atherosclerosis: current pathogenesis and therapeutic options
Weber, C., & Noels, H. (2011) · Nature Medicine · doi:10.1038/nm.2538 · Cited by 2,203
Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,147
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885 · cited 1×
“, exposure to pore-forming gasdermin D, mixed lineage kinase domain-like protein activation, P2X7 purinergic receptor activation, cathepsin release and lysosomal damage), the up-regulation of mitochondrial reactive oxygen species (ROS), the following release of oxidized DNA from mitochondria and the cardiolipin extern…”
BackgroundInterleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798 · cited 1×
“Clinical analysis displays that an anti-IL-1β antibody and IL-1 receptor antagonist (IL-1RA) ameliorated β-cell function and glucose control levels [52,53].”
BackgroundFatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330 · cited 3×
“However, these data have not been confirmed in Txnip-/- macrophages [59].”
BackgroundCooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299 · cited 2×
“It forms an amyloid structure in the pancreatic islets of T2D patients [50].”
BackgroundGlucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Willing, B. P., Dicksved, J., Halfvarson, J., Andersson, A. F., Lucio, M., Zheng, Z., Järnerot, G., Tysk, C., Jansson, J. K., & Engstrand, L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.049 · Cited by 1,032
Autoimmune T cell responses in the central nervous system
Goverman, J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2550 · Cited by 1,030
Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome
Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
Zaki, M. H., Boyd, K. L., Vogel, P., Kastan, M. B., Lamkanfi, M., & Kanneganti, T.-D. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.003 · Cited by 989
Levy, M., Thaiss, C. A., Zeevi, D., Dohnalová, L., Zilberman-Schapira, G., Mahdi, J. A., David, E., Savidor, A., Korem, T., Herzig, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.048 · Cited by 960
Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935
Angiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
Bauer, C., Duewell, P., Mayer, C., Lehr, H. A., Fitzgerald, K. A., Dauer, M., Tschopp, J., Endres, S., Latz, E., & Schnurr, M. (2010) · Gut · doi:10.1136/gut.2009.197822 · Cited by 906
Innate immunity in Alzheimer's disease
Heneka, M. T., Golenbock, D. T., & Latz, E. (2015) · Nature Immunology · doi:10.1038/ni.3102 · Cited by 902
Kawaguchi, M., Takahashi, M., Hata, T., Kashima, Y., Usui, F., Morimoto, H., Izawa, A., Takahashi, Y., Masumoto, J., Koyama, J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.982777 · Cited by 884
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Lamkanfi, M., Mueller, J. L., Vitari, A. C., Misaghi, S., Fedorova, A., Deshayes, K., Lee, W. P., Hoffman, H. M., & Dixit, V. M. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200903124 · Cited by 820 · cited 1×
“To date, the most used drug for the treatment of T2D is glibenclamide, capable of blocking the activation of the NLRP3 inflammasome [65].”
BackgroundParkinson’s disease: genetics and pathogenesis
Shulman, J. M., De Jager, P. L., & Feany, M. B. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130242 · Cited by 801
Yan, Y., Jiang, W., Spinetti, T., Tardivel, A., Castillo, R., Bourquin, C., Guarda, G., Tian, Z., Tschopp, J., & Zhou, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.015 · Cited by 784 · cited 16×
“These data propose CB1R as therapeutic target in T2D [62].”
BackgroundInfluentialLack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748
Mechanism of NLRP3 inflammasome activation
Sutterwala, F. S., Haasken, S., & Cassel, S. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12458 · Cited by 736
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Lee, H.-M., Kim, J.-J., Kim, H. J., Shong, M., Ku, B. J., & Jo, E.-K. (2013) · Diabetes · doi:10.2337/db12-0420 · Cited by 734
Inflammasome is a central player in the induction of obesity and insulin resistance
Stienstra, R., van Diepen, J. A., Tack, C. J., Zaki, M. H., van de Veerdonk, F. L., Perera, D., Neale, G. A., Hooiveld, G. J., Hijmans, A., Vroegrijk, I., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100255108 · Cited by 727
Stienstra, R., Joosten, L. A. B., Koenen, T., van Tits, B., van Diepen, J. A., van den Berg, S. A. A., Rensen, P. C. N., Voshol, P. J., Fantuzzi, G., Hijmans, A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.011 · Cited by 676
The NLRP3 inflammasome in acute myocardial infarction
Toldo, S., & Abbate, A. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.161 · Cited by 665
NLRP3 Inflammasome and Inflammatory Bowel Disease
Zhen, Y., & Zhang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00276 · Cited by 649
Csak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24341 · Cited by 645
Walsh, J. G., Muruve, D. A., & Power, C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3638 · Cited by 637
Gringhuis, S. I., Kaptein, T. M., Wevers, B. A., Theelen, B., van der Vlist, M., Boekhout, T., & Geijtenbeek, T. B. H. (2012) · Nature Immunology · doi:10.1038/ni.2222 · Cited by 613
Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome
Imaeda, A. B., Watanabe, A., Sohail, M. A., Mahmood, S., Mohamadnejad, M., Sutterwala, F. S., Flavell, R. A., & Mehal, W. Z. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35958 · Cited by 607
Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies
Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055375 · Cited by 585
Coccia, M., Harrison, O. J., Schiering, C., Asquith, M. J., Becher, B., Powrie, F., & Maloy, K. J. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111453 · Cited by 580
Gurung, P., Anand, P. K., Malireddi, R. K. S., Vande Walle, L., Van Opdenbosch, N., Dillon, C. P., Weinlich, R., Green, D. R., Lamkanfi, M., & Kanneganti, T.-D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302839 · Cited by 558
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
Villani, A.-C., Lemire, M., Fortin, G., Louis, E., Silverberg, M. S., Collette, C., Baba, N., Libioulle, C., Belaiche, J., Bitton, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.285 · Cited by 525
Sandanger, Ø., Ranheim, T., Vinge, L. E., Bliksøen, M., Alfsnes, K., Finsen, A. V., Dahl, C. P., Askevold, E. T., Florholmen, G., Christensen, G., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt091 · Cited by 524
Dupaul-Chicoine, J., Yeretssian, G., Doiron, K., Bergstrom, K. S. B., McIntire, C. R., LeBlanc, P. M., Meunier, C., Turbide, C., Gros, P., Beauchemin, N., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.02.012 · Cited by 517
Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
Vande Walle, L., Van Opdenbosch, N., Jacques, P., Fossoul, A., Verheugen, E., Vogel, P., Beyaert, R., Elewaut, D., Kanneganti, T.-D., van Loo, G., et al. (2014) · Nature · doi:10.1038/nature13322 · Cited by 506
Duncan, J. A., Bergstralh, D. T., Wang, Y., Willingham, S. B., Ye, Z., Zimmermann, A. G., & Ting, J. P.-Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611496104 · Cited by 498
Daniels, M. J. D., Rivers-Auty, J., Schilling, T., Spencer, N. G., Watremez, W., Fasolino, V., Booth, S. J., White, C. S., Baldwin, A. G., Freeman, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12504 · Cited by 442
A functional role for NLRP6 in intestinal inflammation and tumorigenesis
Chen, G. Y., Liu, M., Wang, F., Bertin, J., & Núñez, G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100412 · Cited by 436
NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis
Hirota, S. A., Ng, J., Lueng, A., Khajah, M., Parhar, K., Li, Y., Lam, V., Potentier, M. S., Ng, K., Bawa, M., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21478 · Cited by 431
Gris, D., Ye, Z., Iocca, H. A., Wen, H., Craven, R. R., Gris, P., Huang, M., Schneider, M., Miller, S. D., & Ting, J. P.-Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904145 · Cited by 429
Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R.-M., Wang, E., Ma, W., Haines, D., O'hUigin, C., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100199 · Cited by 429
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
Netea, M. G., Joosten, L. A. B., Lewis, E., Jensen, D. R., Voshol, P. J., Kullberg, B. J., Tack, C. J., van Krieken, H., Kim, S.-H., Stalenhoef, A. F., et al. (2006) · Nature Medicine · doi:10.1038/nm1415 · Cited by 424
Ito, M., Shichita, T., Okada, M., Komine, R., Noguchi, Y., Yoshimura, A., & Morita, R. (2015) · Nature Communications · doi:10.1038/ncomms8360 · Cited by 412
NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., Zhang, M., Zhang, Y., & An, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104771 · Cited by 408
Mallat, Z., Corbaz, A., Scoazec, A., Graber, P., Alouani, S., Esposito, B., Humbert, Y., Chvatchko, Y., & Tedgui, A. (2001) · Circulation Research · doi:10.1161/hh1901.098735 · Cited by 407
Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome
Cho, M.-H., Cho, K., Kang, H.-J., Jeon, E.-Y., Kim, H.-S., Kwon, H.-J., Kim, H.-M., Kim, D.-H., & Yoon, S.-Y. (2014) · Autophagy · doi:10.4161/auto.29647 · Cited by 395
Jourdan, T., Godlewski, G., Cinar, R., Bertola, A., Szanda, G., Liu, J., Tam, J., Han, T., Mukhopadhyay, B., Skarulis, M. C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3265 · Cited by 388
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
Elhage, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00343-2 · Cited by 373
Lissner, D., Schumann, M., Batra, A., Kredel, L.-I., Kühl, A. A., Erben, U., May, C., Schulzke, J.-D., & Siegmund, B. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000384 · Cited by 368
Chalkiadaki, A., & Guarente, L. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.003 · Cited by 352
Qiu, Z., Lei, S., Zhao, B., Wu, Y., Su, W., Liu, M., Meng, Q., Zhou, B., Leng, Y., & Xia, Z.-Y. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9743280 · Cited by 351
Anakinra for Rheumatoid Arthritis: A Systematic Review
MERTENS, M., & SINGH, J. A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090074 · Cited by 344
Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
Janson, J., Soeller, W. C., Roche, P. C., Nelson, R. T., Torchia, A. J., Kreutter, D. K., & Butler, P. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7283 · Cited by 342
Hu, B., Elinav, E., Huber, S., Strowig, T., Hao, L., Hafemann, A., Jin, C., Wunderlich, C., Wunderlich, T., Eisenbarth, S. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307575110 · Cited by 326
Liu, Y., Lian, K., Zhang, L., Wang, R., Yi, F., Gao, C., Xin, C., Zhu, D., Li, Y., Yan, W., et al. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0415-z · Cited by 321
Jha, S., Srivastava, S. Y., Brickey, W. J., Iocca, H., Toews, A., Morrison, J. P., Chen, V. S., Gris, D., Matsushima, G. K., & Ting, J. P.-Y. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4088-10.2010 · Cited by 310
Freigang, S., Ampenberger, F., Weiss, A., Kanneganti, T.-D., Iwakura, Y., Hersberger, M., & Kopf, M. (2013) · Nature Immunology · doi:10.1038/ni.2704 · Cited by 307
The role of intestinal microbiota and the immune system.
Purchiaroni, F., Tortora, A., Gabrielli, M., Bertucci, F., Gigante, G. E., Ianiro, G., Ojetti, V., Scarpellini, E., & Gasbarrini, A. (2013) · PubMed · Cited by 300
Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection
Aachoui, Y., Sagulenko, V., Miao, E. A., & Stacey, K. J. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.04.004 · Cited by 296 · cited 1×
“It stops pathogen replication inside the cell, promotes the phagocytosis of remaining bacteria and induces the release of pro-inflammatory proteins involved in the pathogenesis of different inflammatory chronic diseases [14,15].”
BackgroundPerera, A. P., Fernando, R., Shinde, T., Gundamaraju, R., Southam, B., Sohal, S. S., Robertson, A. A. B., Schroder, K., Kunde, D., & Eri, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-26775-w · Cited by 295
NLRP3 at the interface of metabolism and inflammation
Haneklaus, M., & O'Neill, L. A. J. (2015) · Immunological Reviews · doi:10.1111/imr.12285 · Cited by 294
Controversies in HIV-associated neurocognitive disorders
Nightingale, S., Winston, A., Letendre, S., Michael, B. D., McArthur, J. C., Khoo, S., & Solomon, T. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70137-1 · Cited by 294
Anakinra Therapy for Non-cancer Inflammatory Diseases
Cavalli, G., & Dinarello, C. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01157 · Cited by 292
Inoue, M., Williams, K. L., Gunn, M. D., & Shinohara, M. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201836109 · Cited by 288
NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis
Guo, C., Fu, R., Wang, S., Huang, Y., Li, X., Zhou, M., Zhao, J., & Yang, N. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13167 · Cited by 285
Finucane, O. M., Lyons, C. L., Murphy, A. M., Reynolds, C. M., Klinger, R., Healy, N. P., Cooke, A. A., Coll, R. C., McAllan, L., Nilaweera, K. N., et al. (2015) · Diabetes · doi:10.2337/db14-1098 · Cited by 281
Johann, S., Heitzer, M., Kanagaratnam, M., Goswami, A., Rizo, T., Weis, J., Troost, D., & Beyer, C. (2015) · Glia · doi:10.1002/glia.22891 · Cited by 277
Drivers of age‐related inflammation and strategies for healthspan extension
Goldberg, E. L., & Dixit, V. D. (2015) · Immunological Reviews · doi:10.1111/imr.12295 · Cited by 274
The Inflammasome Puts Obesity in the Danger Zone
Stienstra, R., Tack, C. J., Kanneganti, T.-D., Joosten, L. A. B., & Netea, M. G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.011 · Cited by 271
NLRP3: A promising therapeutic target for autoimmune diseases
Shen, H.-H., Yang, Y.-X., Meng, X., Luo, X.-Y., Li, X.-M., Shuai, Z.-W., Ye, D.-Q., & Pan, H.-F. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.020 · Cited by 271
Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice
Gomez, D., Baylis, R. A., Durgin, B. G., Newman, A. A. C., Alencar, G. F., Mahan, S., St. Hilaire, C., Müller, W., Waisman, A., Francis, S. E., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0124-5 · Cited by 256
Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
Menu, P., Pellegrin, M., Aubert, J.-F., Bouzourene, K., Tardivel, A., Mazzolai, L., & Tschopp, J. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.18 · Cited by 251
Ritter, M., Gross, O., Kays, S., Ruland, J., Nimmerjahn, F., Saijo, S., Tschopp, J., Layland, L. E., & Prazeres da Costa, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010337107 · Cited by 243
Sun, H.-J., Ren, X.-S., Xiong, X.-Q., Chen, Y.-Z., Zhao, M.-X., Wang, J.-J., Zhou, Y.-B., Han, Y., Chen, Q., Li, Y.-H., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.470 · Cited by 243
Toldo, S., Marchetti, C., Mauro, A. G., Chojnacki, J., Mezzaroma, E., Carbone, S., Zhang, S., Van Tassell, B., Salloum, F. N., & Abbate, A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.043 · Cited by 242
Blockade of interleukin 1 in type 1 diabetes mellitus
Mandrup-Poulsen, T., Pickersgill, L., & Donath, M. Y. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.271 · Cited by 237
Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS
Walsh, J. G., Reinke, S. N., Mamik, M. K., McKenzie, B. A., Maingat, F., Branton, W. G., Broadhurst, D. I., & Power, C. (2014) · Retrovirology · doi:10.1186/1742-4690-11-35 · Cited by 231
Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling
Antonopoulos, C., Russo, H. M., El Sanadi, C., Martin, B. N., Li, X., Kaiser, W. J., Mocarski, E. S., & Dubyak, G. R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.652321 · Cited by 229
Bhaskar, V., Yin, J., Mirza, A. M., Phan, D., Vanegas, S., Issafras, H., Michelson, K., Hunter, J. J., & Kantak, S. S. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.026 · Cited by 225
Liu, W., Yin, Y., Zhou, Z., He, M., & Dai, Y. (2014) · Inflammation Research · doi:10.1007/s00011-013-0667-3 · Cited by 222
NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
Luo, B., Huang, F., Liu, Y., Liang, Y., Wei, Z., Ke, H., Zeng, Z., Huang, W., & He, Y. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00519 · Cited by 213
Pellegrini, C., Antonioli, L., Lopez-Castejon, G., Blandizzi, C., & Fornai, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00036 · Cited by 211
Reduced Incidence and Severity of Collagen-Induced Arthritis in Mice Lacking IL-18
Wei, X.-Q., Leung, B. P., Arthur, H. M. L., McInnes, I. B., & Liew, F. Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.517 · Cited by 207
The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis
Dayer, J.-M. (2003) · Rheumatology · doi:10.1093/rheumatology/keg326 · Cited by 207
Hook, V. Y. H., Kindy, M., & Hook, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708362200 · Cited by 207
Mathews, R. J., Robinson, J. I., Battellino, M., Wong, C., Taylor, J. C., Eyre, S., Churchman, S. M., Wilson, A. G., Isaacs, J. D., Hyrich, K., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203276 · Cited by 201
Yao, X., Zhang, C., Xing, Y., Xue, G., Zhang, Q., Pan, F., Wu, G., Hu, Y., Guo, Q., Lu, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01917-2 · Cited by 195
Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes
Legrand-Poels, S., Esser, N., L’homme, L., Scheen, A., Paquot, N., & Piette, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.013 · Cited by 194
Inoue, M., Williams, K. L., Oliver, T., Vandenabeele, P., Rajan, J. V., Miao, E. A., & Shinohara, M. L. (2012) · Science Signaling · doi:10.1126/scisignal.2002767 · Cited by 194
Caspase-1 Regulates the Inflammatory Process Leading to Autoimmune Demyelination
Furlan, R., Martino, G., Galbiati, F., Poliani, P. L., Smiroldo, S., Bergami, A., Desina, G., Comi, G., Flavell, R., Su, M. S., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2403 · Cited by 194
Bracey, N. A., Beck, P. L., Muruve, D. A., Hirota, S. A., Guo, J., Jabagi, H., Wright Jr, J. R., MacDonald, J. A., Lees‐Miller, J. P., Roach, D., et al. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.068338 · Cited by 188
β-amyloid, microglia, and the inflammasome in Alzheimer’s disease
Gold, M., & El Khoury, J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0518-0 · Cited by 187
Liu, L., Dong, Y., Ye, M., Jin, S., Yang, J., Joosse, M. E., Sun, Y., Zhang, J., Lazarev, M., Brant, S. R., et al. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw219 · Cited by 187
Choulaki, C., Papadaki, G., Repa, A., Kampouraki, E., Kambas, K., Ritis, K., Bertsias, G., Boumpas, D. T., & Sidiropoulos, P. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0775-2 · Cited by 183
The structure of rotational bands in alpha-cluster nuclei
Bijker, R. (2015) · EPJ Web of Conferences · doi:10.1051/epjconf/20159301011 · Cited by 180
Shi, F.-D., Takeda, K., Akira, S., Sarvetnick, N., & Ljunggren, H.-G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3099 · Cited by 178
The Inflammasome in Atherosclerosis and Type 2 Diabetes
Masters, S. L., Latz, E., & O’Neill, L. A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001902 · Cited by 169
Cocco, M., Pellegrini, C., Martínez-Banaclocha, H., Giorgis, M., Marini, E., Costale, A., Miglio, G., Fornai, M., Antonioli, L., López-Castejón, G., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01624 · Cited by 165
The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis
Williams, T. M., Leeth, R. A., Rothschild, D. E., Coutermarsh-Ott, S. L., McDaniel, D. K., Simmons, A. E., Heid, B., Cecere, T. E., & Allen, I. C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402098 · Cited by 162
Ratsimandresy, R. A., Indramohan, M., Dorfleutner, A., & Stehlik, C. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.35 · Cited by 161
Regulation of HMGB1 release by inflammasomes
Lu, B., Wang, H., Andersson, U., & Tracey, K. J. (2013) · Protein & Cell · doi:10.1007/s13238-012-2118-2 · Cited by 161
Rao, V. R., Ruiz, A. P., & Prasad, V. R. (2014) · AIDS Research and Therapy · doi:10.1186/1742-6405-11-13 · Cited by 161
Origins and Effects of Extracellular α-synuclein: Implications in Parkinson’s Disease
Lee, S.-J. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0012-9 · Cited by 159
Shaw, P. J., Lukens, J. R., Burns, S., Chi, H., McGargill, M. A., & Kanneganti, T.-D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000217 · Cited by 159
Role of caspase-1 and interleukin-1β in acetaminophen-induced hepatic inflammation and liver injury
Williams, C. D., Farhood, A., & Jaeschke, H. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.07.004 · Cited by 158
Mamik, M. K., Hui, E., Branton, W. G., McKenzie, B., Chisholm, J., Cohen, É. A., & Power, C. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9708-3 · Cited by 156
Boaru, S. G., Borkham‐Kamphorst, E., Tihaa, L., Haas, U., & Weiskirchen, R. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-49 · Cited by 147
Ruscitti, P., Cipriani, P., Benedetto, P. D., Liakouli, V., Berardicurti, O., Carubbi, F., Ciccia, F., Alvaro, S., Triolo, G., & Giacomelli, R. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12667 · Cited by 139
Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease
Béraud, D., & Maguire‐Zeiss, K. A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70008-6 · Cited by 135
Wang, Y., Viollet, B., Terkeltaub, R. A., & Liu‐Bryan, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206074 · Cited by 135
Matsuki, T., Nakae, S., Sudo, K., Horai, R., & Iwakura, Y. (2006) · International Immunology · doi:10.1093/intimm/dxh379 · Cited by 133
Zhang, H., Wang, S., Huang, Y., Wang, H., Zhao, J., Gaskin, F., Yang, N., & Fu, S. M. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.02.001 · Cited by 132
Inflammasome activation has an important role in the development of spontaneous colitis
Zhang, J., Fu, S., Sun, S., Li, Z., & Guo, B. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.1 · Cited by 130
Hu, S., Peng, L., Kwak, Y.-T., McElvania, E., Pasare, C., Malter, J. S., Hooper, L. V., & Zaki, H. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.040 · Cited by 130
Activation of NLRP3 inflammasome by crystalline structures via cell surface contact
Hari, A., Zhang, Y., Tu, Z., Detampel, P., Stenner, M. D., Ganguly, A., & Shi, Y. (2014) · Scientific Reports · doi:10.1038/srep07281 · Cited by 128
Inflammasomes and Metabolic Disorders: Old Genes in Modern Diseases
Robbins, G. R., Wen, H., & Ting, J. P. ‐. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.029 · Cited by 123
Gene Silencing of NALP3 Protects Against Liver Ischemia–Reperfusion Injury in Mice
Zhu, P., Duan, L., Chen, J., Xiong, A., Xu, Q. L., Zhang, H., Zheng, F., Tan, Z., Gong, F., & Fang, M. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.145 · Cited by 122
Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver
Ganz, M. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i43.4772 · Cited by 122
Gut Microbiota Protects against Gastrointestinal Tumorigenesis Caused by Epithelial Injury
Zhan, Y., Chen, P.-J., Sadler, W. D., Wang, F., Poe, S., Núñez, G., Eaton, K. A., & Chen, G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0827 · Cited by 120
NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage
Bruder-Nascimento, T. B., Ferreira, N. S., Zanotto, C. Z., Ramalho, F. N. Z., Pequeno, I. O., Olivon, V. C., Neves, K. B., Alves-Lopes, R., Campos, E., Silva, C. A. A., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.024369 · Cited by 118
Shi, J., Zhang, C., Sun, X., Cheng, X., Wang, J., Zhang, Y., Xu, J. L., & Zou, H. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12066 · Cited by 116
Loher, F., Bauer, C. A., Landauer, N., Schmall, K., Siegmund, B., Lehr, H. A., Dauer, M., Schoenharting, M., Endres, S., & Eigler, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.057059 · Cited by 116
NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis
Chung, H., Vilaysane, A., Lau, A. N., Stahl, M., Morampudi, V., Bondzi‐Simpson, A., Platnich, J. M., Bracey, N. A., French, M.-C., Beck, P., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.14 · Cited by 116
The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation
Shi, F., Yang, L., Kouadir, M., Yang, Y., Wang, J., Zhou, X., Yin, X., & Zhao, D. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-73 · Cited by 115
Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis
Wang, Y., Gao, B., & Xiong, S. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00441.2014 · Cited by 115
Lazaridis, L.-D., Pistiki, A. C., Giamarellos‐Bourboulis, E. J., Georgitsi, M., Damoraki, G., Polymeros, D., Dimitriadis, G., & Τriantafyllou, Κ. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4609-8 · Cited by 115
Caspase-1 expression in multiple sclerosis plaques and cultured glial cells
Ming, X., Li, W., Maeda, Y., Blumberg, B. M., Raval, S., Cook, S. D., & Dowling, P. C. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00030-8 · Cited by 111
Zhang, W., Xu, X., Kao, R. L. C., Mele, T. S., Kvietys, P. R., Martin, C. M., & Rui, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107639 · Cited by 109
NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective
Sandanger, Ø., Gao, E., Ranheim, T., Bliksøen, M., Kaasbøll, O. J., Alfsnes, K., Nymo, S. H., Rashidi, A., Ohm, I. K., Attramadal, H., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.12.051 · Cited by 105
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis
Italiani, P., Carlesi, C., Giungato, P., Puxeddu, I., Borroni, B., Bossù, P., Migliorini, P., Siciliano, G., & Boraschi, D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-94 · Cited by 103
Li, R., Lu, K., Wang, Y., Chen, M., Zhang, F., Shen, H., Yao, D., Gong, K., & Zhang, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.021 · Cited by 101
de Nooijer, R., von der Thüsen, J. H., Verkleij, C. J. N., Kuiper, J., Jukema, J. W., van der Wall, E. E., van Berkel, T. J. C., & Biessen, E. A. L. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000147126.99529.0a · Cited by 99
Hecker, A., Küllmar, M., Wilker, S., Richter, K., Zakrzewicz, A., Atanasova, S., Mathes, V., Timm, T., Lerner, S., Klein, J., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1400974 · Cited by 98
Dumas, A., Amiable, N., Vaccari, J. P. D. R., Chae, J. J., Keane, R. W., Lacroix, S., & Vallières, L. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004150 · Cited by 94
Yin, Z., Deng, T., Peterson, L. E., Yu, R., Lin, J., Hamilton, D. J., Reardon, P. R., Sherman, V., Winnier, G. E., Zhan, M., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.018 · Cited by 92
Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium
Rosengren, S., Hoffman, H. M., Bugbee, W., & Boyle, D. L. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.025577 · Cited by 87
Pierantonelli, I., Rychlicki, C., Agostinelli, L., Giordano, D. M., Gaggini, M., Fraumene, C., Saponaro, C., Manghina, V., Sartini, L., Mingarelli, E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11744-6 · Cited by 82 · cited 1×
“These events, in turn, led to bacterial translocation and the increased expressions of both the LPS receptor, TLR4, and the double-stranded bacterial DNA receptor, TLR9, in the liver [102].”
BackgroundTsutsui, H., Imamura, M., Fujimoto, J., & Nakanishi, K. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/641865 · Cited by 82
Role of caspase-1 in regulation of triglyceride metabolism
Kotas, M. E., Jurczak, M. J., Annicelli, C., Gillum, M. P., Cline, G. W., Shulman, G. I., & Medzhitov, R. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301996110 · Cited by 80
Altaf, A., Qu, P., Zhao, Y., Wang, H., Lou, D., & Niu, N. (2015) · Coronary Artery Disease · doi:10.1097/mca.0000000000000255 · Cited by 80
Guo, W., Liu, W., Jin, B., Geng, J., Li, J., Ding, H., Wu, X., Xu, Q., Sun, Y., & Gao, J. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2014.12.009 · Cited by 76
Role of Genetic Alterations in the NLRP3 and CARD8 Genes in Health and Disease
Paramel, G. V., Sirsjö, A., & Fransén, K. (2015) · Mediators of Inflammation · doi:10.1155/2015/846782 · Cited by 76
D’Amico, R., Fusco, R., Cordaro, M., Siracusa, R., Peritore, A. F., Gugliandolo, E., Crupi, R., Scuto, M. C., Cuzzocrea, S., Paola, R. D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062144 · Cited by 76
Self-citationRamaswamy, V., Walsh, J. G., Sinclair, D. B., Johnson, E. S., Tang‐Wai, R., Wheatley, B. M., Branton, W. G., Maingat, F. G., Snyder, T. J., Gross, D. W., et al. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-152 · Cited by 75
Wang, L., Qu, P., Zhao, J., & Chang, Y. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.44871 · Cited by 71
Peelen, E., Damoiseaux, J. G. M. C., Muris, A., Knippenberg, S. A. M., Smolders, J., Hupperts, R., & Thewissen, M. M. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.10.008 · Cited by 71
Ferreira, N. S., Bruder-Nascimento, T. B., Pereira, C. A., Zanotto, C. Z., Prado, D. D. S., da Silva, J. F., Rassi, D. M., Foss‐Freitas, M. C., Alves-Filho, J. C., Carlos, D., et al. (2019) · Cells · doi:10.3390/cells8121595 · Cited by 70
Heitzer, M., Kaiser, S., Kanagaratnam, M., Zendedel, A., Hartmann, P., Beyer, C., & Johann, S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0322-4 · Cited by 69
Chen, M., Xing, Y., Lu, A., Fang, W. Y., Sun, B., Chen, C., Liao, W., & Meng, G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500865 · Cited by 67
NLRP3 and CARD8 Polymorphisms Influence Higher Disease Activity in Rheumatoid Arthritis
Jenko, B., Praprotnik, S., Tomšič, M., & Dolžan, V. (2016) · Journal of Medical Biochemistry · doi:10.1515/jomb-2016-0008 · Cited by 61
Nlrp3 plays no role in acute cardiac infarction due to low cardiac expression
Jong, W. M. C., Leemans, J. C., Weber, N. C., Juffermans, N. P., Schultz, M. J., Hollmann, M. W., & Zuurbier, C. J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.148 · Cited by 59
Complexity and dynamics of host–fungal interactions
Cottier, F., & Pavelka, N. (2012) · Immunologic Research · doi:10.1007/s12026-012-8265-y · Cited by 56
Kadhim, H., Deltenre, P., Martin, J.-J., & Sébire, G. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2015.11.022 · Cited by 54
NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease
Perera, A. P., Kunde, D., & Eri, R. D. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170201162414 · Cited by 54
Fusco, R., D’Amico, R., Cordaro, M., Gugliandolo, E., Siracusa, R., Peritore, A. F., Crupi, R., Impellizzeri, D., Cuzzocrea, S., & Paola, R. D. (2018) · Oncotarget · doi:10.18632/oncotarget.25823 · Cited by 54
Self-citationPellegrini, C., Fornai, M., Colucci, R., Benvenuti, L., D’Antongiovanni, V., Natale, G., Fulceri, F., Giorgis, M., Marini, E., Gastaldi, S., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01405 · Cited by 54
Fusco, R., Gugliandolo, E., Biundo, F., Campolo, M., Paola, R. D., & Cuzzocrea, S. (2017) · The FASEB Journal · doi:10.1096/fj.201601349r · Cited by 52
Self-citationTan, H., Liu, X., Bi, X., Xing, S., Li, L., Gong, H., Zhong, M., Wang, Z., Zhang, Y., & Zhang, W. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.053 · Cited by 44
Prion Pathogenesis in the Absence of NLRP3/ASC Inflammasomes
Nuvolone, M., Sorce, S., Schwarz, P., & Aguzzi, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117208 · Cited by 39
Obesity development in caspase-1-deficient mice
Wang, H., Capell, W. H., JiSun, Y. O. O. N., Faubel, S. G., & Eckel, R. H. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.59 · Cited by 39
Regulation of the gut microbiome by inflammasomes
Chen, G. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.011 · Cited by 38
Effects of chronically increased VEGF‐A on the aging heart
Marneros, A. G. (2017) · The FASEB Journal · doi:10.1096/fj.201700761rr · Cited by 27
Cited by
DAMPs and DAMP-sensing receptors in inflammation and diseases
Ma, M., Jiang, W., & Zhou, R. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.002 · Cited by 515
Protein Corona Formation on Lipid Nanoparticles Negatively Affects the NLRP3 Inflammasome Activation
Debnath, M., Forster, J., Ramesh, A., & Kulkarni, A. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00329 · Cited by 60
D’Amico, R., Fusco, R., Siracusa, R., Impellizzeri, D., Peritore, A. F., Gugliandolo, E., Interdonato, L., Sforza, A. M., Crupi, R., Cuzzocrea, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126471 · Cited by 51
Self-citationSun, X., Chen, Z., Yu, L., Zeng, W., Sun, B., Fan, H., & Bai, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1205323 · Cited by 33
“The NLRP3 inflammasome is ubiquitous among epithelial cells and immunocytes (Fusco et al., 2020).”
BackgroundOdoribacter laneus protects intestinal barrier by bile acid-FXR axis in acute pancreatitis
Gu, R., Li, J., Qi, J., Sun, R., Wu, H., & Jin, B. (2026) · AMB Express · doi:10.1186/s13568-026-02071-z · Cited by 2
“Such activation facilitates Caspase-1 cleavage and subsequent IL-1β and IL-18 release, contributing to colonic injury pathogenesis (Fusco et al. 2020).”
Metadata
- Authors
- Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., & Di Paola, R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-06-13
- Volume
- 21
- Issue
- 12
- Pages
- 4223
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3034487638
- Cited by
- 290
- References
- 187
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.